Polyglutamine (polyQ)-expansions in different proteins cause nine neurodegenerative diseases. While polyQ aggregation is a key pathological hallmark of these diseases, how aggregation relates to pathogenesis remains contentious. In this chapter, we review what is known about the aggregation process and how cells respond and interact with the polyQexpanded proteins. We cover detailed biophysical and structural studies to uncover the intrinsic features of polyQ aggregates and concomitant effects in the cellular environment to examine the functional consequences of polyQ aggregation and how cells may attempt to intervene and guide the aggregation process.
Introduction
Nine neurodegenerative diseases, including Huntington Disease (HD), result from an expansion in a CAG-codon sequence, encoding polyglutamine (polyQ), within a gene specific to each disease [1] [2] [3] [4] [5] [6] [7] [8] . The expanded polyQ sequence cause the host proteins to form large intracellular aggregates known as inclusions 9 . In HD, the polyQ expansion occurs within exon 1 of the huntingtin (Htt) protein 1 . For the other diseases, the polyQ expansions occur in different ataxin-proteins (for spinocerebellar ataxias (SCA) 1, 2 3, 6, 7, and 17 [2] [3] [4] [5] [6] [7] [8] ); the androgen receptor (for spinobulbar muscular atrophy (SBMA) 10 ) and the atrophin-1 protein (for dentatorubral pallidoluysian atrophy (DRPLA) 11, 12 ). For all these diseases the penetrance, age of onset and severity correlates with polyQ length beyond a critical disease threshold of approximately 40 residues depending on the disease protein 13 . For HD, pathological disease Polling / 2 threshold is 37 glutamines 9 . Here we discuss how polyQ expansions affect the structure and aggregation properties of the host proteins and proposed mechanisms for how this process relates to pathogenesis.
PolyQ structure, assembly and aggregation
Detailed insight to the core intrinsic features of polyQ and their effects on the host protein has been gleaned from in vitro studies on purified proteins. Purified polyQ-containing peptides and proteins form SDS-insoluble, high molecular weight protein aggregates 14, 15 .
These aggregates are similar in morphology to the amyloid fibrils formed by proteins in other neurodegenerative diseases such as the prion protein in Creutzfeldt-Jakob disease and A peptide in Alzheimer's disease [14] [15] [16] [17] . The formation of aggregates occurs when polyQ-lengths reach the disease threshold, which suggests aggregation is fundamental to disease mechanisms 9, 18 . Aggregation of small polyQ containing peptides and polyQ-expanded Htt has been proposed to occur via a nucleated growth mechanism, which is similar to models generally described for amyloid fibril formation 15, [19] [20] [21] [22] . In this model, aggregation proceeds rapidly upon the formation of an energetically unfavourable nucleus 19 . A key feature of nucleated aggregation is the so called "lag phase", a characteristic slow stage of aggregate accumulation early in the aggregation pathway, which can be eliminated by seeding preformed fibril fragments of Htt and polyQ-expanded peptides into the reaction 15, 22 . In addition, the aggregation rates are time-and concentration-dependent, which is a feature of nucleated kinetics 23, 24 .
How the fibrils extend once nucleated is still not clearly resolved. One model posits fibril elongation to occur via cycles of monomer binding ("docking") and subsequent intramolecular rearrangements ("locking") 20, 21 . However other studies have shown monomers Polling / 3 form small soluble oligomers that result in the formation of rod-like particles prior to assembling into the mature insoluble fibrils (Figure 1 ) [25] [26] [27] . These soluble aggregates/oligomers are spherical structures with a diameter spanning 5-65 nm that assemble into rod-like clusters and more rarely annular clusters 27, 28 . How oligomers transition to fibrils is unclear, however, they dissipate as fibrils assemble suggesting they directly convert to fibrils or they form transiently in a competing non-amyloidogenic pathway 27 .
The transient nature of the aggregation nucleus and early oligomeric intermediates has made their direct measurement a technical challenge. However, modelling of aggregation data of synthetic polyQ-peptides has suggested that the aggregation nucleus is an energetically unfavourable conformation of monomer 23, 29 . This suggests that nucleation requires the monomer to change conformation into an aggregation-permissive form, rather than by condensation of multiple monomers into an oligomer.
More recent studies have further indicated polyQ monomers to have unusual structural attributes that challenge the conventional nucleated growth model for aggregation kinetics and suggest novel mechanisms of cellular toxicity 25, [30] [31] [32] . First, while polyQ monomers are classically disordered by circular dichroism and NMR spectroscopic assessment [33] [34] [35] , they are unusually compact compared to other "disordered" proteins 25, 31, 32 . The monomers also are heterogeneous in conformation like other disordered proteins, yet unlike classic disordered proteins seem to be more mechanically rigid 30, 31 . In addition, fluorescence correlation spectroscopy (FCS) and fluorescence resonance energy transfer (FRET) experiments suggest polyQ monomers become increasingly compact upon increasing polyQ length 25, 32 . These results have been proposed to result from water acting as an unfavourable solvent of the glutamine sidechains relative to intra-chain interactions, which locks monomers into slowlyexchanging, compact globule conformations 36, 37 . The consequence of rigid compact monomers in vivo is unknown, however, compact monomers may be difficult to degrade by Polling / 4 the proteasome, which requires substrate proteins to be unfolded. Indeed, polyQ sequences have been reported to be resistant to proteasomal degradation 38 .
The formation of compact and rigid monomer conformations is likely to also influence the mode of aggregation because the forces driving compact monomers and aggregation are both likely to be governed by a preference to exclude interfaces with water 32 . Intramolecular glutamine side chain and peptide backbone interactions are proposed to be more favourable within a polyQ sequence than for chain-solvent interactions 32 . Hence longer polyQ lengths increasingly promote the favourability of distant parts of the polyQ chain to interact and stabilize a compact monomer structure 25 . However, glutamine residues can interact equivalently at many different points within a polyQ peptide sequence, which suggests a high level of heterogeneity in compact, largely rigid monomer conformations 31 .
While polyQ monomers have an overall disordered conformation, fibrils formed from these proteins are similar to those of other amyloid forming proteins and have a high β-sheet content 14, 39, 40 . β-Sheet formation seems to occur after the early steps of aggregation since soluble aggregates retain a classically disordered structure It is still not clear as to how the β-structure of polyQ fibrils is arranged and it could be affected by parameters such as flanking residues and buffer conditions 42, 43 . Various -strand assembly models have been proposed including parallel and anti-parallel β-sheets, polar -Polling / 5 sheet zipper, β-helix nanotubes, superpleated or cross-β structures [44] [45] [46] [47] [48] [49] [50] [51] . Regardless of the structure, the β-sheet content contributes to the robust stability of the aggregates, which are resistant to normally denaturing detergents such as SDS 14, 15, 26, 41, 52 .
PolyQ aggregation in cells
Htt aggregates assemble into micrometer-sized punctate structures in cells, known as inclusion bodies, in human brain 73, 74 . A number of proteins with a role in actin-cytoskeleton organization have been shown to influence polyQ-aggregation such as α-Pix, which binds Htt and promotes soluble intermolecular Htt interactions 73 . Htt also interacts with profilin-2a, increases degradation of profilin-1 and 2a, reducing the F-actin to G-actin ratio 75 .
Overexpression of profilin reduces aggregation of expanded Htt fragments, while overexpression of cofilin, an important modulator of the actin cytoskeleton, enhances aggregation 74 . Htt has been reported to bind actin directly in vitro through its N-terminus, although this has not been detected in cells 76 .
Htt aggregation in vivo involves a number of post-translational modifications including proteolytic fragmentation, which may be part of normal cellular functions of Htt.
One of the earliest in vivo processing events preceding inclusion formation is cleavage of Htt by caspases, calpains and/or other proteases 77 . N-terminal Htt fragments are readily detected Polling / 8 in aggregates and are thought to comprise the majority of the protein in inclusion bodies [78] [79] [80] . Different Htt fragments display varying aggregation properties in cells, indicating that cleavage of full-length Htt influences its intracellular localisation, aggregation and toxicity [81] [82] [83] [84] . In addition, cleavage is influenced by phosphorylation at residues such as ser-536, which is necessary for calpain cleavage and associated events leading to toxicity 85 .
Other post-translational modifications may also be critical factors influencing Htt aggregation and inclusion formation. Huntington has been shown to be phosphorylated, palmitoylated, ubiquitinated, SUMOylated and acetylated, and changes in modification status of polyQ-expanded Htt influences the ability of the protein to aggregate [86] [87] [88] [89] . PolyQ-expanded Htt has been shown to be acetylated at lys-444 in human HD brain and mouse HD models which may reflect attempts to remove the mutant protein by macroautophagy, since enhanced lys-444 acetylation by CREB binding protein (CBP) facilitates trafficking to autophagosomes and increases macroautophagic clearance and neuroprotection 90 . Phosphorylation and palmitoylation may also play roles in mediating Htt shift to inclusions, removal or aggregation. For example, phosphorylation of serine 421 by Akt and serum-and glucocorticoid-induced kinase (SGK) correlates with a reduced number of nuclear inclusions 91, 92 . Reducing palmitoylation of Htt via a decreased interaction of Htt with interacting protein 14 (HIP14), leads to an increased inclusion formation and neuronal toxicity 89 .
Cellular toxicity and disease mechanism
Some of the abnormal events known to occur in HD include trancriptional dysregulation, mitochondrial dysfunction, impaired vesicle transport, dysfunctional axonal transport and aberrant neuronal signaling, including excitotoxicity 93, 94 . However, there is no consensus to a single or combination of multiple mechanisms by which polyQ expansion Polling / 9 definitively leads to toxicity which suggests a multifactorial basis for toxicity (or an insufficient understanding of the molecular pathways involved).
Most mechanisms proposed involve a toxic gain-of-function from polyQ expansion although loss-of-function has also been suggested to contribute to disease by separate mechanisms to the toxic gain of function 95, 96 . This is primarily based on Htt being essential for viability since mouse knockouts are embryonic lethal 97 , but also on conditional knockouts in adult mice that lead to neurodegeneration 98 . However, mice can be rescued by mutant Htt, indicating that the polyQ-expanded protein is essentially functional, although this rescue may be incomplete due to these mice having testicular abnormalities 99 . When mice containing mutant Htt are backcrossed into lines with wildtype Htt, the additional gene dosage of the wildtype Htt partially supresses toxicity, which suggests that aggregation of the mutant Htt causes a loss of function and contributes to toxicity [100] [101] [102] .
Regardless of a potential role for a loss of Htt normal function in disease, the ectopic overexpression of pathogenic polyQ-peptides (but not non-pathogenic lengths) leads to neurodegeneration in Drosophila 96 , indicating that pathogenic lengths of polyQ are intrinsically toxic. The mechanism of toxicity may thus include two major components. One is that mutant Htt aggregation coaggregates the wild-type allelic form (or other proteinsdiscussed below) and hence acts in a dominant negative manner to inactivate normal Htt function 103 and, two, the aggregates themselves are directly neurotoxic 71, [104] [105] [106] [107] [108] [109] [110] [111] . While the nine polyQ-diseases have different characteristics which could arise from expression and protein context differences, the phenotype of these diseases become more similar in the extreme polyQ lengths (eg juvenile disease cases) which suggests that a direct gain of toxic function from expanded polyQ is the dominant mode to pathogenesis intermediates and an impairment of protein homeostasis 110, 111 . Abnormal interactions can be mediated through co-aggregation with other proteins rich in glutamine and impair their normal cellular functions 71, [104] [105] [106] [107] [108] [109] or cause the proteins to shift into abnormal cellular locations once they have co-aggregated [112] [113] [114] . For example, monomeric or small oligomeric Htt can interact with a polyQ sequence in the TATA-binding protein (TBP), which changes its conformation and impairs its function 115 . Alternatively, large protein aggregates may physically obstruct subcellular processes such as axonal transport 116 . PolyQ expansion may also be toxic by disrupting binding of Htt to its normal ligands, since Htt interacts with a large number of proteins many of which it may act as a scaffold for in signalling complexes 117 .
Indeed, Htt is thought to have roles in vesicle transport, endocytosis, postsynaptic signalling, transcription, anti-apoptotic processes and cytoskeletal reorganization, which provides much scope for abnormal interactions interfering very broadly with important cellular activities 94, 117, 118 .
Another postulated gain of toxic function comes from polyQ-expansions altering interactions with membrane lipids. PolyQ peptides can interact with phospholipids and penetrate lipid bilayers to form channels, which could play roles in toxicity 119, 120 or assist in the spread of protein aggregates to surrounding cells in a prion-like manner 121 . Moreover, mutant Htt has higher affinities to lipid rafts and penetration into lipid bilayers in vitro than wild-type forms of Htt 122, 123 . These mechanisms may be shared more generally with other neurodegenerative disorders, such as Parkinson's disease, where α-synuclein assembles into annular oligomers that can form pores in membranes 124 Another proposed mechanism of toxicity involves the disruption of cellular protein quality control homeostasis mechanisms that keep the proteome folded, called proteostasis.
For reasons that are not known, proteostasis naturally declines upon ageing, which also correlates with aggregation of misfolded proteins [125] [126] [127] [128] [129] . Aggregation-prone proteins also stress the proteostasis capacity, suggesting potential for a feedback loop to exacerbate damage 110, 130, 131 . This phenomenon was shown elegantly in C. elegans whereby expression of polyQ-expanded proteins led to aggregation of temperature-sensitive mutants at what was otherwise permissive temperatures, which suggests that the presence of polyQ exhausts proteostasis resources that are necessary to prevent other proteins in the proteome from misfolding 110 . The organismal capacity to process misfolding-prone proteins may become overloaded over time, leading to an accumulation of misfolded and abnormal proteins that burden proteostasis mechanisms 110, 111 . Weak folding mutations and polymorphisms throughout the genome can function as modifiers of proteostasis capacity, which may contribute to the wide phenotypic variability in the age of onset for a given pathogenic polyQlength 110 .
An intriguing feature of this proteostasis mode of toxicity is that many proteins that modulate aggregation of polyQ-expanded proteins are components of protein quality control mechanisms that relate to proteostasis such as the unfolded protein response (UPR), heat shock response, the ubiquitin-proteasome system (UPS) and clearance via autophagy.
Clearance of mutant Htt is mediated through both the UPS and autophagy and cell culture models 142, 143 . These chaperones appear to target specific aggregate populations, since Hsp70 and Hsp40 associate with a distinct set of oligomers 144 . Together they act to inhibit the formation of these oligomer types, which supresses caspase-3 activity and apoptosis 144 . However, these chaperones may also play roles in increasing aggregation or assembly into inclusions under certain situations. For example Hsp70 and Hsp40 can decrease oligomer levels, while increasing fibril formation in vitro Other elements of the protein quality control network, such as macroautophagy are likely pivotal players in HD disease mechanisms [146] [147] [148] . Macroautophagy regulates cellular clearance of organelles and aggregated proteins by engulfment of material into autophagosomes. Activation of macroautophagy ameliorates HD pathology in animal models while its loss increases the accumulation of misfolded proteins and enhances neurodegeneration 149, 150, 151 . Critically, there are polymorphisms in the autophagy-related gene 7 (Atg7) that lead to earlier HD onset demonstrating the importance of autophagy While most research has focused on the Htt protein as the toxic entity, additional data has implicated CAG trinucleotide repeat mRNA, which encodes the polyQ sequences, as directly toxic in addition to the protein 159 . RNA-mediated toxicity of non-coding CTG trinucleotide repeats is well established to cause dysfunction in myotonic dystrophy as well as SCA8 [160] [161] [162] [163] [164] [165] [166] . Recently a similar mode of toxicity was demonstrated in Drosophila for SCA3 159 . Although the underlying mechanism is unknown, expression of ataxin-3 encoded with a CAACAG sequence instead of a direct CAGCAG repeat reduced toxicity and expression of non-coding CAG repeats induced progressive neural dysfunction 159 . RNAmediated toxicity adds an extra dimension of complexity to the disease.
Differences in toxicity in the nervous system and periphery
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Finally, one area that remains largely unexplored is why different cell types seem to respond differently to the toxic effects of polyQ. The extent and nature of cellular dysfunction is likely to substantially differ across cell types and developmentally since HD pathology most severely affects the striatal neurons even though Htt is expressed ubiquitously from early embryogenesis 167 . Furthermore, the pathology outside the brain is complex and less well understood. Mutant Htt inclusion formation does occur outside the central nervous system 168, 169 and there is peripheral toxicity and inclusion formation in the muscle cells 170 , β-cells of the islets of Langerhans in the pancreas 171 and cardiac myocytes 172 , which lead to muscular atrophy, as well as diabetes 173 and heart failure in HD, respectively 174 .
Why striatal neurons seem most sensitive to aggregation remains a puzzle. Possible explanations lie in neurons being post-mitotic, which leaves them incapable of using asymmetric cell division as a possible mechanism to lessen toxic burden 175, 176 . Other studies have pointed to a decreased organismal capacity to handle protein aggregation upon ageing, which may more selectively sensitise neurons to damage 127, 177 . In addition, early developmental effects in the brain may compound later damage from protein aggregation since there are signs of structural brain abnormalities occurring well before clinical diagnosis of HD and in knock-in mouse model of HD 178, 179, 180 .
In conclusion, while aggregation caused by polyQ-expansions seems central to the pathogenesis of HD, much remains to be discovered as to the precise means this occurs. We believe that the instrinsic aggregation and the core biophysical properties of polyQ-expanded proteins fundamentally shape the mechanisms underpinning pathogenesis and new approaches are needed to study this aspect in situ. Indeed knowledge of these mechanisms will likely be of paramount importance to informing us of invaluable targets for therapeutic intervention, especially for emerging approaches that stimulate quality control mechanisms against misfolded and aggregating proteins 181 . These principles also apply more broadly to other
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